<?xml version="1.0" encoding="UTF-8"?>
<p id="p0365">Plasma antibodies contribute to the elimination of infection via directly binding to pathogens and neutralizing them, or by activating indirect immune responses, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity, or phagocytosis 
 <xref rid="b0675" ref-type="bibr">[135]</xref>, 
 <xref rid="b0680" ref-type="bibr">[136]</xref>. In COVID-19 patients, their plasma contains active specific neutralizing antibodies (which mediate the anti-infective function of plasma therapy) and non-neutralizing antibodies (which might boost prophylaxis and improvement of patients).
</p>
